Insights into a Phase II study evaluating ANX005 in wAIHA

In this video, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, shares some insights into a Phase II study evaluating ANX005, a novel complement antibody, for the treatment of warm autoimmune hemolytic anemia (wAIHA). This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.